Shmuel Ben Zvi
Director/Board Member bei BANK LEUMI LE-ISRAEL B.M.
Vermögen: - $ am 31.03.2024
Profil
Shmuel Ben Zvi is an Independent Director at Bank Leumi Le-Israel B.M.
since 2015 and at Protalix Biotherapeutics, Inc. since 2022.
He is also the Manager & Owner of Shmuel (Muli) Ben Zvi Ltd.
Dr. Ben Zvi previously served as the Deputy CEO, VP-Finance & Strategy at Teva Pharmaceutical Industries Ltd.
from 2004 to 2014.
He was an Independent Non-Executive Director at Vascular Biogenics Ltd.
from 2018 to 2023.
Additionally, he held the position of Head-Budget Department at Israel Ministry of Defense from 2000 to 2004.
Dr. Ben Zvi has an educational background from Tel-Aviv University, where he obtained undergraduate, graduate, and doctorate degrees.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 29.09.2023 | 0 ( -.--% ) | - $ | 31.03.2024 |
Aktive Positionen von Shmuel Ben Zvi
| Unternehmen | Position | Beginn |
|---|---|---|
| BANK LEUMI LE-ISRAEL B.M. | Director/Board Member | 29.07.2015 |
| PROTALIX BIOTHERAPEUTICS, INC. | Director/Board Member | 30.06.2022 |
| Shmuel (Muli) Ben Zvi Ltd. | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Shmuel Ben Zvi
| Unternehmen | Position | Ende |
|---|---|---|
| NOTABLE LABS, LTD. | Director/Board Member | 16.10.2023 |
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Corporate Officer/Principal | 01.12.2014 |
| Israel Ministry of Defense | Corporate Officer/Principal | 01.01.2004 |
| SOL-GEL TECHNOLOGIES LTD. | Director/Board Member | - |
Ausbildung von Shmuel Ben Zvi
| Tel-Aviv University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 4 |
|---|---|
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Health Technology |
| BANK LEUMI LE-ISRAEL B.M. | Finance |
| SOL-GEL TECHNOLOGIES LTD. | Health Technology |
| PROTALIX BIOTHERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
| Israel Ministry of Defense | Government |
Vascular Biogenics Ltd.
 Vascular Biogenics Ltd. BiotechnologyHealth Technology Vascular Biogenics Ltd. is a clinical-stage biopharmaceutical company, which engages in the development of next-generation, targeted medicines for difficult-to-treat medical conditions. Its product candidates are built off of its platform technologies: Vascular Targeting System (VTS), a gene-based technology targeting newly formed blood vessels and Monocyte Targeting Technology (MTT), an antibody-based technology able to specifically inhibit monocyte migration for immune-inflammatory applications. The company was founded by Dror Harats and Jacob George on January 27, 2000 and is headquartered in Modi'in, Israel. | Health Technology |
| Shmuel (Muli) Ben Zvi Ltd. |
